Manuscripts
Showing 1554 manuscripts.
Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants
Citation
Kathleen M. Powis, Mauricio Pinilla, Flynn McMorrow, Alice Stek, Kristina M. Brooks, David E. Shapiro, Kevin Knowles, Ahizechukwu C. Eke, Elizabeth Greene, Allison Agwu, Lourdes Topete, Renee Browning, Nahida Chakhtoura, Priyanka Arora, Xiaoying Huang, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2026 Protocol Team. Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants. Journal of Acquired Immune Deficiency Syndromes. 2025. 98: 300-307. PMID: 39813286Year
2025
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2026
Bone mineral content, growth, and renal health of infants with perinatal exposure to maternal dolutegravir vs efavirenz and tenofovir disoproxil fumarate vs tenofovir alafenamide: the randomized IMPAACT 2010 (VESTED) trial
Citation
Tapiwa Mbengeranwa, Lauren Ziemba, Sean S. Brummel, Ben Johnston, Haseena Cassim, Gerhard Theron, Zukiswa Ngqawana, Deo Wabwire, Katie McCarthy, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda, IMPAACT 2010/VESTED study team and investigators. Bone mineral content, growth, and renal health of infants with perinatal exposure to maternal dolutegravir vs efavirenz and tenofovir disoproxil fumarate vs tenofovir alafenamide: the randomized IMPAACT 2010 (VESTED) trial. Journal of AIDS. 2025. PMID: 40001275Year
2025
Journal
Journal of AIDS
Study
IMPAACT 2010
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Citation
Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M. Best, John H. Moye, Ellen Townley, Avy Violari, Barbara Heckman, Sarah Buisson, Rodica M. Van Solingen-Ristea, Edmund V. Capparelli, Mark A. Marzinke, Elizabeth D. Lowenthal, Shawn Ward, Chelsea Krotje, Ryan Milligan, Allison L. Agwu, Jenny Huang, Amy Cheung, Cynthia McCoig, Dwight E. Yin, Gilly Roberts, Herta Crauwels, Veerle Van Eygen, Sara Zabih, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Violet Korutaro, Aditya H. Gaur, IMPAACT 2017 Collaborators. Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2025. 12: e191-e200. PMID: 40049924Year
2025
Journal
Lancet HIV
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.
Citation
Jennifer A. Hughes, Mauricio Pinilla, Kristina M. Brooks, Ahizechukwu C. Eke, Alice Stek, Brookie M. Best, Mark Mirochnick, Renee Browning, Lubbe Wiesner, Kathleen George, Kevin Knowles, Petra De Koker, Nahida Chakhtoura, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Marije van Schalkwyk, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.. Clinical Pharmacology. 2025. PMID: 40155501Year
2025
Journal
Clinical Pharmacology
Study
P1026S
The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis
Citation
Sharon Sawe, Lufina Tsirizani, Richard Court, Kamunkhwala Gausi, Asanda Poswa, Tasnim Badat, Lubbe Wiesner, Marian Loveday, Gary Maartens, Francesca Conradie, Paolo Denti. The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis. Antimicrobial Agents and Chemotherapy. 2025. PMID: 40167446Year
2025
Journal
Antimicrobial Agents and Chemotherapy
Study
P1078
Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics
Citation
Grace Montepiedra, Lisa Aaron, Gerhard Theron, Katie McCarthy, Sarah Bradford, Tsungai Chipato, Tichoana Vhembo, Lynda Stranix-Chibanda, Deo Wabwire, Gaerolwe Masheto, Patrick Jean-Philippe, Timothy R Sterling, Adriana Weinberg, Amita Gupta. Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. 2025. PMID: 40237651Year
2025
Study
P1078
Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa
Citation
Flavia Matovu Kiweewa, Lynda Stranix-Chibanda, Nonhlanhla Yende-Zuma, Sufia Dadabhai, Maxensia Owor, Sherika Hanley, Mandisa Nyati, Lameck Chinula, John M Pettifor, Sean S Brummel, Jim Aizire, Taha E Taha, Todd T Brown, Mary Glenn Fowler, Maternal Bone Health Study team. Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa. AIDS. 2025. PMID: 39918445Year
2025
Journal
AIDS
Study
P1084s
The Representative Studies Rubric: A Tool for Diversity in Clinical Trials
Citation
Brian Minalga, Rona Siskind, Russell Campbell, Tyler Adamson, Mary Allegra Cermak, Annet Davis, Eddie Givens, Molly Dyer, Katie McCarthy, Nicole A. Montañez, Rhonda White, RSR Working Group. The Representative Studies Rubric: A Tool for Diversity in Clinical Trials. American Journal of Bioethics. 2025. 1-15. PMID: 40293363Year
2025
Journal
American Journal of Bioethics
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376Year
2024
Journal
Lancet HIV
Study
P1115
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Citation
Lauren Ziemba, Rebecca Zash, Lameck Chinula, Roger Shapiro, Jeffrey S A Stringer, Nahida Chakhtoura, Frances Nakayiwa, Ben Johnston, Avy Violari, Chelsea Krotje, Lee Fairlie, Katie McCarthy, Victoria Ndyanabangi, Patrick Jean-Philippe, Teacler G. Nematadzira, Paul Sax, Sherika Hanley, Judith S. Currier, Esau João, Shahin Lockman, Linda Aurpibul, VESTED Study Team, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Risa M. Hoffman, Gerhard Theron, Sean Brummel, Cristina Barroso Hofer. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024. ciae001PMID: 38180851Year
2024
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010